178 related articles for article (PubMed ID: 14632763)
21. Serum levels of monocyte chemotactic protein-3/CCL7 are raised in patients with systemic sclerosis: association with extent of skin sclerosis and severity of pulmonary fibrosis.
Yanaba K; Komura K; Kodera M; Matsushita T; Hasegawa M; Takehara K; Sato S
Ann Rheum Dis; 2006 Jan; 65(1):124-6. PubMed ID: 16344498
[TBL] [Abstract][Full Text] [Related]
22. Increased interleukin-17 production in patients with systemic sclerosis.
Kurasawa K; Hirose K; Sano H; Endo H; Shinkai H; Nawata Y; Takabayashi K; Iwamoto I
Arthritis Rheum; 2000 Nov; 43(11):2455-63. PubMed ID: 11083268
[TBL] [Abstract][Full Text] [Related]
23. Endothelial expression of nitric oxide synthases and nitrotyrosine in systemic sclerosis skin.
Cotton SA; Herrick AL; Jayson MI; Freemont AJ
J Pathol; 1999 Oct; 189(2):273-8. PubMed ID: 10547586
[TBL] [Abstract][Full Text] [Related]
24. Elevated matrix metalloproteinase-9 in patients with systemic sclerosis.
Kim WU; Min SY; Cho ML; Hong KH; Shin YJ; Park SH; Cho CS
Arthritis Res Ther; 2005; 7(1):R71-9. PubMed ID: 15642145
[TBL] [Abstract][Full Text] [Related]
25. Low levels of nitric oxide (NO) in systemic sclerosis: inducible NO synthase production is decreased in cultured peripheral blood monocyte/macrophage cells.
Allanore Y; Borderie D; Hilliquin P; Hernvann A; Levacher M; Lemaréchal H; Ekindjian OG; Kahan A
Rheumatology (Oxford); 2001 Oct; 40(10):1089-96. PubMed ID: 11600736
[TBL] [Abstract][Full Text] [Related]
26. Longitudinal analysis of serum cytokine concentrations in systemic sclerosis: association of interleukin 12 elevation with spontaneous regression of skin sclerosis.
Matsushita T; Hasegawa M; Hamaguchi Y; Takehara K; Sato S
J Rheumatol; 2006 Feb; 33(2):275-84. PubMed ID: 16465658
[TBL] [Abstract][Full Text] [Related]
27. Possible pro-inflammatory role of heparin-binding epidermal growth factor-like growth factor in the active phase of systemic sclerosis.
Hirabayashi M; Asano Y; Yamashita T; Miura S; Nakamura K; Taniguchi T; Saigusa R; Takahashi T; Ichimura Y; Miyagawa T; Yoshizaki A; Miyagaki T; Sugaya M; Sato S
J Dermatol; 2018 Feb; 45(2):182-188. PubMed ID: 29044628
[TBL] [Abstract][Full Text] [Related]
28. Serum levels of soluble vascular endothelial growth factor receptor-2 in patients with systemic sclerosis.
Jinnin M; Makino T; Kajihara I; Honda N; Makino K; Ogata A; Ihn H
Br J Dermatol; 2010 Apr; 162(4):751-8. PubMed ID: 19886888
[TBL] [Abstract][Full Text] [Related]
29. Fibroblast expression of the coactivator p300 governs the intensity of profibrotic response to transforming growth factor beta.
Bhattacharyya S; Ghosh AK; Pannu J; Mori Y; Takagawa S; Chen G; Trojanowska M; Gilliam AC; Varga J
Arthritis Rheum; 2005 Apr; 52(4):1248-58. PubMed ID: 15818659
[TBL] [Abstract][Full Text] [Related]
30. Interleukin-35 is upregulated in systemic sclerosis and its serum levels are associated with early disease.
Tomcik M; Zerr P; Palumbo-Zerr K; Storkanova H; Hulejova H; Spiritovic M; Kodet O; Stork J; Becvar R; Vencovsky J; Pavelka K; Filkova M; Distler JH; Senolt L
Rheumatology (Oxford); 2015 Dec; 54(12):2273-82. PubMed ID: 26231346
[TBL] [Abstract][Full Text] [Related]
31. In situ expression and serum levels of tumor necrosis factor-alpha receptors in patients with early stages of systemic sclerosis.
Gruschwitz MS; Albrecht M; Vieth G; Haustein UF
J Rheumatol; 1997 Oct; 24(10):1936-43. PubMed ID: 9330935
[TBL] [Abstract][Full Text] [Related]
32. Nitrite production in mouse 3T3 fibroblasts by bleomycin-stimulated peripheral blood mononuclear cell factors.
Yamamoto T; Katayama I; Nishioka K
Clin Exp Rheumatol; 1999; 17(3):343-6. PubMed ID: 10410269
[TBL] [Abstract][Full Text] [Related]
33. Scleroderma keratinocytes promote fibroblast activation independent of transforming growth factor beta.
McCoy SS; Reed TJ; Berthier CC; Tsou PS; Liu J; Gudjonsson JE; Khanna D; Kahlenberg JM
Rheumatology (Oxford); 2017 Nov; 56(11):1970-1981. PubMed ID: 28968684
[TBL] [Abstract][Full Text] [Related]
34. Radical oxygen species production induced by advanced oxidation protein products predicts clinical evolution and response to treatment in systemic sclerosis.
Servettaz A; Guilpain P; Goulvestre C; Chéreau C; Hercend C; Nicco C; Guillevin L; Weill B; Mouthon L; Batteux F
Ann Rheum Dis; 2007 Sep; 66(9):1202-9. PubMed ID: 17363403
[TBL] [Abstract][Full Text] [Related]
35. Elevated serum insulin-like growth factor (IGF-1) and IGF binding protein-3 levels in patients with systemic sclerosis: possible role in development of fibrosis.
Hamaguchi Y; Fujimoto M; Matsushita T; Hasegawa M; Takehara K; Sato S
J Rheumatol; 2008 Dec; 35(12):2363-71. PubMed ID: 19004037
[TBL] [Abstract][Full Text] [Related]
36. Altered expression of CD63 and exosomes in scleroderma dermal fibroblasts.
Nakamura K; Jinnin M; Harada M; Kudo H; Nakayama W; Inoue K; Ogata A; Kajihara I; Fukushima S; Ihn H
J Dermatol Sci; 2016 Oct; 84(1):30-39. PubMed ID: 27443953
[TBL] [Abstract][Full Text] [Related]
37. Serum IL-33 levels are raised in patients with systemic sclerosis: association with extent of skin sclerosis and severity of pulmonary fibrosis.
Yanaba K; Yoshizaki A; Asano Y; Kadono T; Sato S
Clin Rheumatol; 2011 Jun; 30(6):825-30. PubMed ID: 21246230
[TBL] [Abstract][Full Text] [Related]
38. Chemokine expression by systemic sclerosis fibroblasts: abnormal regulation of monocyte chemoattractant protein 1 expression.
Galindo M; Santiago B; Rivero M; Rullas J; Alcami J; Pablos JL
Arthritis Rheum; 2001 Jun; 44(6):1382-6. PubMed ID: 11407698
[TBL] [Abstract][Full Text] [Related]
39. Circulating γ/δ T cells in systemic sclerosis exhibit activated phenotype and enhance gene expression of proalpha2(I) collagen of fibroblasts.
Ueda-Hayakawa I; Hasegawa M; Hamaguchi Y; Takehara K; Fujimoto M
J Dermatol Sci; 2013 Jan; 69(1):54-60. PubMed ID: 23159281
[TBL] [Abstract][Full Text] [Related]
40. Trichloroethylene induce nitric oxide production and nitric oxide synthase mRNA expression in cultured normal human epidermal keratinocytes.
Shen T; Zhu QX; Yang S; Ding R; Ma T; Ye LP; Wang LJ; Liang ZZ; Zhang XJ
Toxicology; 2007 Oct; 239(3):186-94. PubMed ID: 17719164
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
